HOME >> BIOLOGY >> NEWS
Dietary component kills bacterial cause of ulcers and stomach cancer

*This release has been updated on May 22 at 1:00PM.*

A bacterium responsible for the vast majority of stomach cancers, a leading cause of cancer death worldwide, and ulcers may have met its match, scientists from Johns Hopkins and the French National Scientific Research Center report in the May 28 issue of the Proceedings of the National Academy of Sciences.

The research team discovered that sulforaphane, a compound found in broccoli and broccoli sprouts, kills the bacterium in laboratory studies. The findings should lead quickly to clinical trials to see whether dietary intake of vegetables containing sulforaphane can relieve infection, the researchers say.

In all but 15 to 20 percent of cases, combinations of powerful antibiotics can kill helicobacter pylori, the bacterium that was recognized 20 years ago as the cause of debilitating stomach ulcers and often fatal stomach cancers. Unfortunately, the regions of the world where the infection is most common are the same places where using antibiotics is most economically and logistically difficult.

"In some parts of Central and South America, Africa and Asia, as much as 80 percent to 90 percent of the population is infected with helicobacter, likely linked to poverty and conditions of poor sanitation," says study leader Jed Fahey, a plant physiologist in the Department of Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine. "If future clinical studies show that a food can relieve or prevent diseases associated with this bacterium in people, it could have significant public health implications in the United States and around the world."

In their laboratory experiments, the scientists discovered that purified sulforaphane even killed helicobacter that was resistant to commonly used antibiotics. They also proved that sulforaphane can kill the bacterium whether it's inside or outside cells. In people, cells lining the stomach can act as reservoirs of helicob
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
27-May-2002


Page: 1 2 3

Related biology news :

1. Dietary supplement shows promise for improving immune function in the elderly
2. Dietary supplement many not lower prostate cancer risk
3. Dietary ginger may work against cancer growth
4. Dietary soy reduces pain, inflammation in rats
5. Dietary changes can lower colon cancer risk in families with a history of the disease
6. Dietary supplements make old rats youthful, may help rejuvenate aging humans, according to UC Berkeley study
7. Dietary approaches to stop hypertension diet reduces cholesterol and long-term cardiovascular risk
8. Dietary study finds marijuana users have normal nutritional status, risky lifestyle habits
9. Dietary fibre supplements may be harmful
10. Dietary fat itself not likely to cause breast cancer
11. Dietary patterns predict heart attack risk in middle-aged men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/28/2020)... PRUSSIA, Pa. and CAMBRIDGE, Mass. (PRWEB) , ... ... ... to solving complex problems for life sciences companies and government agencies, announced that ... life sciences hubs in the country. Tunnell’s Cambridge office will be in the ...
(Date:1/27/2020)... ... ... On Thursday, February 20, 2020 at 10am EST (3pm GMT/UK), join Gary ... Castle, Global Account Manager Medical Device at PRISYM ID for an informative ... deadlines, best practices in creating and submitting product data and best practices in preparing ...
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , a microbiome research ... announced that the company will debut a novel new DNA isolation kit at the ... product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit designed for ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant ... surgery industry at two recent North American investor forums specializing in medical advancements. ... Medical Technologies & Diagnostics Forum on November 21, 2019 in New York City, ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report ... for the vendor qualification process, a critical element of clinical trial set up ... of the vendor qualification process creates delays in initiation in 7% of clinical ...
(Date:1/7/2020)... (PRWEB) , ... January 07, 2020 , ... ... antibody products and services, today announced the launch of its VivopureX™ recombinant mouse ... antibody clones, many originally obtained from rats or hamsters, which Absolute Antibody has ...
(Date:12/31/2019)... (PRWEB) , ... December 31, 2019 , ... ... in expanding its pharmaceutical product development lab in Maryland. Emphasis will ... increased size and expanded capabilities, Vici Health Sciences will be well positioned to ...
Breaking Biology Technology:
Cached News: